Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study

Objective. To investigate if antibodies towards biological TNF-α inhibitors (anti-TNFi Abs) are present in patients with rheumatoid arthritis (RA) in clinical remission and to relate any anti-TNFi Abs to circulating level of TNF-α inhibitor (TNFi). Methods. Patients with RA, treated with infliximab...

Descripción completa

Detalles Bibliográficos
Autores principales: Eng, Grith P., Bendtzen, Klaus, Bliddal, Henning, Stoltenberg, Michael, Szkudlarek, Marcin, Fana, Viktoria, Lindegaard, Hanne M., Omerovic, Emina, Højgaard, Pil, Jensen, Elmo K., Bouchelouche, Pierre N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339793/
https://www.ncbi.nlm.nih.gov/pubmed/25759761
http://dx.doi.org/10.1155/2015/784825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339793/
https://www.ncbi.nlm.nih.gov/pubmed/25759761
http://dx.doi.org/10.1155/2015/784825

Ejemplares similares